Cymusi

Cymusi
Product Description

Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes cymusi. It belongs to formulation category. Indication: indicated to renal transplant recipient to prevent rejection. Contact us for more information.

Huadong medicine Co.,Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Quality Service
  • Supplied from
    China

Huadong medicine Co.,Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)

More Products from Huadong medicine Co.,Ltd. (4)

  • Acarbose

    Product Acarbose

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes acarbose. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Corbrin capsule

    Product Corbrin capsule

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes corbrin capsule. It belongs to formulation category. Functions: nourishes lung and kidney and benefits vital essence. It’s effective for the treatment of cough, asthma, chronic kidney trouble, chroni...
  • Cyclosporine

    Product Cyclosporine

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes cyclosporine. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Cycopin

    Product Cycopin

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes cycopin. It belongs to formulation category. Indication: use to prevent rejection in allograft renal transplant recipient and to treat refractory rejection. Mycophenolate mofetil dispersible table could b...